arrow-circle-full-right arrow-circle-full-up arrow-circle-up arrow-down arrow-right calendar calendar-done facebook flickr home linkedin login pin reload search share signin star twitter video video youtube nav star-plus info signout double-arrow arrow-up checked
Healthcare & Life Sciences

FT Digital Health Summit USA

Unlocking the Value of Disruption

New York |
Speakers include:
Aneesh Chopra

Aneesh Chopra


Mona Siddiqui

Mona Siddiqui

Department of Health and Human Services

Adam  Landman

Adam Landman

Brigham Health


The US digital health industry continues to lead the world in terms of innovation and investment. Digital technologies are increasingly able to improve quality and efficiency and make prevention, diagnosis and treatment more effective, personalized and precise.

In order to realize the true potential of disruption there is the need to adapt to a shifting health landscape and overcome the vulnerabilities of cost, security, engagement and integration. Investment and cooperation, together with clear frameworks and business models, are key to harnessing the power of digital solutions to bring value to healthcare. 

This year’s FT Digital Health Summit USA will explore the benefits, opportunities and complexities of digital disruption. The brightest minds from across the health spectrum will discuss the keys to unlocking value and smoothing the points of friction on the road to successful health transformation.

fallback Add to my Calendar 10/17/2018 08:00:0010/17/2018 16:50:00trueFT Digital Health Summit USAThe US digital health industry continues to lead the world in terms of innovation and investment. Digital technologies are increasingly able to improve quality and efficiency and make prevention, diagnosis and treatment more effective, personalized and precise.In order to realize the true potential of disruption there is the need to adapt to a shifting health landscape and overcome the vulnerabilities of cost, security, engagement and integration. Investment and cooperation, together with clear frameworks and business models, are key to harnessing the power of digital solutions to bring value to healthcare. This year’s FT Digital Health Summit USA will explore the benefits, opportunities and complexities of digital disruption. The brightest minds from across the health spectrum will discuss the keys to unlocking value and smoothing the points of friction on the road to successful health transformation.FT-Digital-Health-Summit-USA47f468a44b5066cfd3a788f714bcbb81MM/DD/YYYY

Countdown Timer

2018 Photos

View the 2018 event photos here

Digital Health Flickr


Evolving Patient Attitudes by Medicalchain

Click Here To Read

Executive Summary

Executive Summary

Download now

Event Brochure

To download the event brochure please fill in the form below. All fields are required

Please complete all the highlighted fields

Form submission failed. Please retry.

For more information about how we use your data please refer to our privacy and cookie policies.

Invites and offers from the FT

Receive exclusive personalised events invitations, carefully-curated offers, future speaking engagements and promotions from Financial Times Live

Thank you for submitting your details. Please download the event brochure.


“Excellent summit bringing together thought inspiring speakers who are leading the digital health world” Abdullah Albeyatti, Medicalchain

“I was so impressed by the quality of the speakers and their open mindedness of how their discipline fits in the healthcare landscape.” Charles Flax, Propellor Communications

“To truly understand the disruption and transformation in the healthcare ecosystem from industry experts, I highly recommend an FT Summit.” Linda Presutti, Epson America

“Thought provoking subject matter, interesting speakers, engaged audience.” RJ Lewis, E-Healthcare Solutions

“Topical and focused. Highest quality content, well curated and well moderated.” Steve Dickman, CBT Advisors


Speakers (25)

Aneesh Chopra

Aneesh Chopra

Former US Chief Technology Officer and President

Aneesh Chopra served as the first US Chief Technology Officer under President Obama (’09-’12) and in 2014, authored, "Innovative State: How New Technologies can Transform Government.” He joined the Board of the Health Care Cost Institute in 2017, earned his MPP from Harvard Kennedy School and BA from The Johns Hopkins University.

Mona Siddiqui

Mona Siddiqui

Chief Data Officer
Department of Health and Human Services

Dr Siddiqui is currently serving as the Chief Data Officer for the Department of Health and Human Services where she is focused on promoting open data, building an enterprise wide data governance structure, streamlined data use agreements, creating a business analytics unit and developing strategic partnerships for data sharing with external stakeholders.  Prior to this role, Dr Siddiqui was at the Centers for Medicare and Medicaid Innovation working towards implementing a rapid cycle testing platform for payment models.  She has also served with the White House Social and Behavioral Sciences Team (“nudge” unit) during the Obama administration leading work in the health space.  She has a MD from the Johns Hopkins School of Medicine and a masters in quantitative methods from the Harvard School of Public Health.

Adam  Landman

Adam Landman

Vice President and Chief Information Officer
Brigham Health

Adam Landman is Chief Information Officer at Brigham Health, Associate Professor of Emergency Medicine at Harvard Medical School, and an attending emergency physician at Brigham and Women’s Hospital (BWH). He is an expert in information systems development and implementation, having led a three-year, $7 million custom software development project to move BWH Emergency Department clinicians from paper-based to electronic documentation, and subsequently helped oversee the implementation of Epic and several critical laboratory information systems. Dr Landman has also led the design and development of mobile apps to securely capture and store clinical images, to improve electronic medication administration and reconciliation, and to improve the patient and staff experience. He also created the BWH Digital Health Innovation Group to spur hospital use of digital technology as well as facilitate appropriate use of digital tools by clinicians, innovators, and researchers. In his current role as Chief Information Officer, he is responsible for developing strategic IT initiatives, with the goal of evolving the next generation of information systems and digital health solutions across the BH enterprise, while maintaining a focus on excellence.

Sue Siegel

Sue Siegel

Chief Innovation Officer and CEO Business Innovations

Sue Siegel is GE’s Chief Innovation Officer and CEO of Business Innovations, leading the development and acceleration of innovation across the company. She has 30+ years of corporate, entrepreneurial and venture capital experience all geared at one thing: turning untapped potential into real value.  In this role, Ms Siegel leads a multimodal innovation engine focused on accelerating start-ups, creating and launching new companies and licensing GE’s intellectual property. She also leads strategy planning and oversees the global marketing function.

Previously, as a Silicon Valley-based venture capitalist at MDV, Ms Siegel led investments and served as Board member for companies in personalized medicine, digital health, and life sciences. Prior to that, she served as President and Board Member of Affymetrix (NASDAQ: AFFX), where she led the company’s transformation from a pre-revenue startup to a global, multi-billion dollar market cap genomics leader. She also held leadership roles at Bio-Rad, DuPont and Amersham.

Ms Siegel has been recognized in Fortune as one of “34 Leaders Who Are Changing Health Care” and as one of “The 100 Most Influential Women in Silicon Valley” by Silicon Valley Business Journal. She is an Aspen Institute Crown Fellow and was featured as a “Multiplier” in the bestselling book: “Multipliers: How the Best Leaders Make Everyone Smarter.”

Ann Mond Johnson

Ann Mond Johnson

American Telemedicine Association

Ann Mond Johnson has 25 years of healthcare leadership and entrepreneurial experience.  Prior to her appointment as CEO of American Telemedicine Association in February 2018, Ms Johnson served as CEO of Zest Health, a technology-enabled service that enables consumers to optimize their benefits by combining a mobile first solution with access to live support.  Before joining Zest, she was Board Chair and Advisor to ConnectedHealth, a leading provider of private insurance exchanges.

In 2000, Ms Johnson co-founded and served as CEO of Subimo, a pioneer in healthcare cost and quality transparency tools for consumers. Under her leadership, Subimo’s reach extended to major national and regional health plans as well as Fortune 500 companies. Subimo was acquired by WebMD in 2006.  Previously, she was Senior Vice President at Sachs Group (now part of IBM Watson/Truven Health), the leading provider of healthcare information for health organizations.

Ms Johnson is a member of the Healthcare Executive Leadership Network and Women Business Leaders of US Healthcare. She serves on the Healthcare Services Strategic Advisory Council for UMB and advised several start-up companies.  She graduated from Carleton College and received both her Masters in Business Administration and Health Care Administration from the University of Minnesota.

David Ross

David Ross

President and CEO
The Task Force For Global Health

David A Ross is President and Chief Executive Officer of The Task Force for Global Health in Atlanta, GA. One of the largest nonprofits in the United States, The Task Force solves large-scale health problems affecting vulnerable populations around the world.

For more than 35 years, Dr Ross has worked in the public, private, and nonprofit sectors on healthcare delivery, medical informatics, and public health informatics. In 2002, he founded the Public Health Informatics Institute at The Task Force and spearheaded its growth to become internationally recognized in the field of public health informatics. Dr Ross has published extensively in peer-reviewed journals about public health informatics. He currently chairs a World Health Organization committee that is developing guidelines for electronic health records. He also serves on the National Committee on Vital and Health Statistics that advises the US Secretary for Health Human Services on health data, statistics, privacy, and national health information policy. Dr Ross has held leadership, administrative, and corporate consultant roles with the US Public Health Service, CDC, a private hospital system in Maryland, and one of the largest health information technology firms.

Dr Ross holds a doctor of science degree in operations research from The Johns Hopkins University and a bachelor of science degree in aerospace engineering from the University of Colorado.

Judy Sewards

Judy Sewards

Vice President, Digital Innovation

Judy Sewards is Vice President of Digital Innovation within the Strategy & Commercial Operations organization at Pfizer, where she is responsible for setting and activating new digital and big data strategies that will help Pfizer meet business and customer needs in the future health landscape. In this role, she leads a team that works with commercial, research and development units to incubate and accelerate transformative capabilities, steward an innovation pipeline, and manage policies and governance to support these activities. By engaging with a diverse range of internal and external partners, the team ensures that the next generation of data and technology solutions help transform how Pfizer brings medicines to market and connects them with the patients they serve.

In her tenure at Pfizer, Judy has held various leadership positions across the organization including team leader for the U.S. Celebrex and Flector Patch businesses, head of the Primary Care U.S. Marketing Innovation Incubator and consumer lead for the iconic Viagra brand. Prior to Pfizer, Judy led client insights, brand strategy and advertising for the Merrill Lynch Global Wealth Management brand. In addition, she brings diverse experience ranging from tech start up to brand planning and management consulting.

Judy received a Bachelor of Arts degree from Smith College, where she also served as a member of the Board of Trustees.

Marcus Osborne

Marcus Osborne

Vice President, Health and Wellness Transformation

Marcus Osborne serves as Vice President, Health and Wellness Transformation for Walmart.  In that role, he is focused on furthering Walmart’s stated goal of improving the healthcare industry in the US by increasing access, quality and affordability in the system for consumers.  Prior to joining Walmart, Marcus was a Senior Management Consultant with Alliance Consulting Group in Boston, Massachusetts.  He also served as the Chief Financial Officer of the Clinton Foundation HIV/AIDS Initiative. Marcus attended the Harvard Business School and received his Master’s in Business Administration, graduating with honors.

Steve Ommen

Steve Ommen

Associate Dean
Center for Connected Care, Mayo Clinic

Steve Ommen leads Mayo Clinic’s telemedicine team, a critical component in Mayo Clinic’s strategy to provide comprehensive care with a seamless patient experience.  He oversees the development of products, services, and systems that bring health care to patients where they need it.  Additionally, he is active in advocating for the advancement of connected care through discussions and presentations at the regional, state, and national levels so that these advancements in health care delivery can be made available to people and patients more broadly. Dr Ommen also holds the positions of Professor of Medicine, Mayo Clinic College of Medicine and Consultant in the Department of Cardiovascular Medicine.  He serves as the Director of the Mayo Hypertrophic Cardiomyopathy Clinic, the largest and longest-standing dedicated HCM Center in the world.  Mayo’s HCM clinic is recognized as a leader in clinical outcomes, research, and patient education.  Dr Ommen is also Co-director of the Structural Heart Disease program, and Medical Director for AskMayoExpert.

Dr Ommen earned his Bachelor of Sciences degree in Biomedical Engineering from Northwestern University.  His undergraduate medical education, Internal Medicine residency and Cardiovascular Diseases fellowship were all completed at Mayo Clinic, Rochester, Minnesota.

Nancy Lublin

Nancy Lublin

CEO and Founder
Crisis Text Line

Nancy Lublin enjoys building things that matter.  In 2003, Lublin came to Do Something to rescue it from the ashes.  She moved everything online, transforming it into, an organization that leverages technology like social media and texting to reach its audience. Today, is one of the largest youth organizations in the world with more than 5.5 million members.

In 2013, while still CEO of, Ms Lublin turned her popular TED talk into her third company. She raised $4 million dollars, hired a team, and launched Crisis Text Line. It processed 1 million messages in its first six months and is heralded as a pioneer in big data for social good.  Her innovative approach to business, teens and technology has transcended the not-for-profit world. She wrote a popular monthly column for Fast Company for two years and has taught graduate-level courses as an adjunct faculty at both Yale and NYU. She is the author of 4 books and sits on the board of McGraw Hill Education and The Truth Initiative, and board chair for

Ms Lublin has a BA from Brown University, an M.Litt from Oxford University (as a Marshall Scholar), and a law degree from New York University.

Chet Robson

Chet Robson

Medical Director, Clinical Programs and Quality

Chet Robson is the Medical Director in the Clinical Office for Walgreen Co.  Dr Robson provides clinical leadership for the Walgreens brand and mission by managing groups providing evidence-based clinical reviews, clinical program development and training, and expanding the Walgreens brand with clinically driven strategy and innovation.  The clinical office provides expertise for pharmacy adherence, immunizations, pharmacovigilance and value creation.  On the healthcare side they support evaluation and development of healthcare services, partnerships, research, and new innovations, including digital and telemedicine. Dr Robson’s vision is to create value in medicine utilizing innovative technology, patient-centered care delivery models, and evidence-based medicine leading to an integrated, comprehensive ecosystem to champion the health and well-being of every community in America.

Saskia Steinacker

Saskia Steinacker

Vice President and Global Lead Digital Transformation

Saskia Steinacker was named Head of Digital Transformation in February 2017. In this capacity, she leads Bayer’s digital transformation in close collaboration with the Board of Management. Together with the divisions and functions she developed the company’s Digital Agenda with a focus on new business models to accelerate new growth. The Digital Agenda enables the organization through a shift of mindset and culture, optimized technology, rapid processes, effective partnerships and expert knowledge on data.

From 2013-2016 she lead the global digital IT function for Bayer and prior to this the BayerNorth America Marketing & Sales IT unit. In 2004 she joined Bayer and held a succession of roles in Marketing, ranging from Multichannel Marketer to Head of Dialog Marketing for Diabetes Care. In this capacity she redesigned the customer interaction of the unit and launched a state-of the art CRM program.

She graduated from Ecosign Academy with a degree in Communication Design and holds a Master in Business Administration from Liverpool University.

Mimi McFaul

Mimi McFaul

Deputy Director
National Mental Health Innovation Center

Mimi is a clinical psychologist who traces her way to the Center via a winding career path in correctional institutions, behavioral health systems improvement and a mental health technology start-up.  She most recently served as Vice President of Campus Partnerships at Grit Digital Health, creating a mental health fitness center for college students from concept to product. She also served for more than 10 years as the Director of Mental Health at the Western Interstate Commission for Higher Education.

Mimi is a graduate of University of Illinois at Urbana-Champaign and the California School of Professional Psychology, San Francisco. She completed her pre- and post-doctoral training at the University of Colorado Denver.  She joined NMHIC because of her frustration with our current mental healthcare system, her steadfast belief that we can find better ways to help people, and a sense of urgency that tells her it’s now or never. 

John Torous

John Torous

Director of the Digital Psychiatry Division
Beth Israel Deaconess Medical Center, Harvard Medical School

John Torous is director of the digital psychiatry division, in the Department of Psychiatry at Beth Israel Deaconess Medical Center, a Harvard Medical School affiliated teaching hospital, where he also serves as a staff psychiatrist and academic faculty. He has a background in electrical engineering and computer sciences and received an undergraduate degree in the field from UC Berkeley before attending medical school at UC San Diego. He completed his psychiatry residency, fellowship in clinical informatics, and master's degree in biomedical informatics at Harvard. Dr Torous is active in investigating the potential of mobile mental health technologies for psychiatry and has published over 75 peer reviewed articles and 5 book chapters on the topic. He serves as editor-in-chief for an academic journal on technology and mental health, JMIR Mental Health, currently leads the American Psychiatric Association’s work group on the evaluation of smartphone apps, and is an advisor to the smartphone mood study within the NIH's one million person All of Us research program.

Heather Bell

Heather Bell

Senior Vice President, Global Head of Digital and Analytics

Heather Bell is Senior Vice President, Global Head of Digital and Analytics at Sanofi and is based in Boston. She works with colleagues across the company to implement, and further develop, Sanofi’s digital strategy. Heather joined Sanofi in 2014 as Vice President Corporate Strategy and Emerging Opportunities and worked with the company’s new leadership to develop Sanofi’s 2020 strategic roadmap.  Dr Bell joined Sanofi from AstraZeneca, where she was Vice President Corporate Strategy in London and then Vice President Program Management in IT/Operations in Boston. Prior to joining AZ in 2011, she spent four years as the first Director of International Strategy at the University of Oxford.

Dr Bell is a former partner at McKinsey & Company in London. As a member of McKinsey’s healthcare practice, she advised clients on strategy and organization, working with pharmaceutical, biotech, and medical device companies and government organizations. She graduated from Harvard and did her doctorate and post-doc at Oxford.

Nelia Padilla

Nelia Padilla

Global Lead, Digital Health

Nelia brings over 20 years of consulting and industry experience working with senior leadership at pharma, biotech, diagnostic and medical device firms. She is passionate about bringing the best tailored treatment, at the right time to patients and facilitating the connection to treatment with digital technologies.  Throughout her career, she developed expertise across a wide range of products while working at the intersection of R&D and commercial, especially in digital health, tailored therapeutics and clinical trial operations.  Recent publications include “Step by step: Leveraging wearables in clinical trials”.

Before joining IQVIA, Nelia spent more than 8 years at Strategy&, a PwC company (formerly Booz & Company) where she co-led the Personalized Medicine offering. Prior to joining Strategy&, Nelia spent over seven years working in regulatory affairs for pharmaceutical, medical device and biotechnology firms in the US, Canada and Europe including Serono and Cell Therapeutics.

Nelia earned a bachelor’s degree in biology from Harvard University and a Master of Business Administration from Yale School of Management and is a native Spanish speaker. 

Paul Ivsin

Paul Ivsin

Managing Director, Clinical Trial Strategy and Recruitment
The Patient Experience Project

Paul Ivsin is the Managing Director of Clinical Trial Strategy and Recruitment at The Patient Experience Project, where he leads all agency programs in pharmaceutical clinical trial recruitment, patient engagement, and analytics. Previously, he served in senior leadership roles in clinical trial strategy at IMS Health, where he led new product development for clinical recruitment as well as feasibility data products and services; and as VP, Consulting Director at TBWAWorldhealth, where he ran the agency’s clinical trial advertising and commercialization consulting group. Earlier in his career, Ivsin cofounded CMJ Solutions, Inc, a company that provided online database solutions for clinical trial enrollment tracking and campaign performance measurement.

Freddy  Abnousi

Freddy Abnousi

Head of Healthcare - Research

Freddy Abnousi is the Head of Healthcare – Research  at Facebook and an Interventional Cardiologist specializing in coronary and structural interventions. Dr Abnousi also serves as Innovation Advisor to the American College of Cardiology and Assistant Professor Adjunct at Yale University School of Medicine. He has previously led innovative healthcare efforts at companies such as McKinsey and Google, and has served as Founder and CMO of CorDynamix Inc., an interventional heart failure company. He completed Fellowships in Cardiovascular Medicine and Interventional Cardiology, as well as Residency in Internal Medicine at Stanford University Medical Center. He was previously a resident surgeon at the University of California, San Francisco. He completed his MD at Stanford University School of Medicine, MBA from Oxford University, and MSc in Health Policy, Planning, & Financing from the London School of Economics.

Jon Gordon

Jon Gordon

NewYork-Presbyterian Ventures

Jon Gordon is Director of NYP Ventures, the strategic venture capital arm of NewYork-Presbyterian, where he is responsible for managing the hospital’s venture investment fund, building strategic partnerships, and managing the hospital’s IP portfolio. Previously, Mr Gordon was a Director in NYP’s Office of Strategy, where he worked on projects ranging from launching the hospital’s Medicare accountable care organization to building a telehealth program. He is also Director of the Health Policy Center at New York-Presbyterian, which advocates for the role of Academic Health Centers in developing solutions for the American health care system. Jon serves on faculty at Weill Cornell Medicine and both teaches about leading healthcare transformation and leads the EMBA capstone program.

Prior to joining NYP, Mr Gordon helped found and served as Chief Operating Officer of EveryDay Medical, an e-commerce-based provider of durable medical equipment. He is a Mentor for the German Accelerator and Blueprint Health incubator, a board member for NYCEDC’s Digital Health Breakthrough Network and a Director of Costs of Care, a not-for-profit dedicated to increasing cost awareness among clinicians. He holds a BA cum laude from Princeton University and an MBA with honors from Columbia Business School. 

John Conrad

John Conrad

Principal, Regulatory and Operational Risk

John Conrad is an Advisory principal in Deloitte's Life Sciences Regulatory and Operations practice of Deloitte & Touche LLP. He advises his clients on numerous aspects of risk consulting, including assisting organizations in performing company-wide risk assessments to address reputational, financial, operational, regulatory, and IT risks as well as developing sustainable governance frameworks to address those risks. He has significant experience providing technology and regulatory services to numerous global pharmaceutical organizations with a focus on IT GxP compliance/computerized system validation, data privacy and protection, cyber security, GRC technologies, risk and regulatory analytics, Sarbanes Oxley compliance, Transparency/Sunshine Act, and health care compliance and ethics.

Mr Conrad has a bachelor degree in Business Administration from Loyola University, MD.

Krista Woodley

Krista Woodley

Senior Director, Quality Healthcare Technology
Johnson & Johnson

Krista Woodley is responsible for quality oversight of J&J’s commercial IT systems, data and analytics platforms, and healthcare technology solutions. She is responsible for driving the implementation of J&J’s Healthcare Technology Quality Strategy, which includes cross-functional engagement from R&D, Commercial, Quality, Regulatory Compliance and IT. Prior to joining J&J Krista worked for Biogen, where she was the head of the company’s Digital Quality and Risk Management function. In this role, she was responsible for quality oversight of Biogen’s Technology solutions, including digital health and enterprise applications/infrastructure. She was accountable for delivering innovative and efficient quality practices which enabled streamlined delivery to business partners and customers, while ensuring that Biogen’s technology programs met regulatory compliance expectations. Krista holds an MBA from Case Western Reserve University in Cleveland, Ohio and a Bachelor of Arts in Zoology from Miami University in Oxford, Ohio.

Jason Gorevic

Jason Gorevic

Teladoc Health

Jason Gorevic is Chief Executive Officer and a member of the board of directors of Teladoc Health. Since taking the reins in 2009, he has led Teladoc Health to its position today as the world’s largest telehealth company, achieving significant growth in revenue, membership and telehealth utilization. Under his leadership the company has established a proven track record of successfully shaping the market and driving healthcare transformation by executing on the strategic vision, delivering award-winning innovation, and effectively integrating each corporate acquisition.

Nationally recognized as a thought leader and trailblazer in the virtual delivery of healthcare, Mr Gorevic is fueled by a passion for improving healthcare outcomes and providing universal access to care. His extensive career in healthcare began at Oxford Health, and he has also held executive leadership roles at WellPoint, Inc. (now Anthem, Inc.) and Empire Blue Cross Blue Shield.  He holds a Bachelor of Arts in International Relations from the University of Pennsylvania.

Marcelo  de Almeida Fonseca

Marcelo de Almeida Fonseca


Marcelo is currently responsible for business development, B2B and care coordination at Dr. Consulta, where Marcelo overseas the Company’s efforts to create a Health Risk Management platform and to establish partnerships with insurers, healthcare providers and corporate clients. 

Prior to joining Dr. Consulta, Marcelo served as CEO of Dal Ben Home Care, in which Marcelo is currently a private investor and Board Member.  Dal Ben is a leading home care services provider in São Paulo.  In July 2014, Marcelo and a group of private investors acquired the controlling stake at Dalben, and Marcelo led the Company’s restructuring process.  In March 2017, Dalben acquired a post-acute care hospital in São Paulo and began the integration of homecare and post-acute care.Prior to joining Dalben, Marcelo had several roles in private equity and investment banking, having done several transactions in healthcare, infrastructure, and real estate.

Marcelo earned an MBA from The Wharton School, University of Pennsylvania (2002) and a BA from Wabash College (1995).

Abdullah Albeyatti

Abdullah Albeyatti

Co-founder and CEO

Abdullah Albeyatti graduated from Imperial College London as a doctor in 2011. He has always had a passion for innovation and problem solving and has developed solutions to inefficiencies he found whilst working in the UK National Health Service. His first notable success was which provided an improved and efficient document generation system for patients and their family doctors following an admission.

He used this as a platform to improve data sharing between all parties involved in the patient's healthcare journey to create Medicalchain. The company's headquarters are in London, UK but plan to roll out this platform worldwide. As well building Medicalchain, Dr Albeyatti continues to serve his community by seeing patients and sits on the board of IGB at NHS Digital.

Dr Albeyatti believes that blockchain technology has the ability to revolutionise the healthcare system by providing a platform that empowers people with full access and control over their own personal health records.

Kristoffer  From

Kristoffer From

Liva Healthcare

Kristoffer From is the co-founder and CEO of Liva Healthcare. Liva Healthcare develops effective digital e-health tools that link patients suffering from chronic lifestyle diseases to healthcare professionals. The goal of the digital platform is to reduce costs and improve quality of life through lifestyle changes. 

Kristoffer is responsible for setting the company’s vision and strategy. He is a serial entrepreneur in the digital health sector. He previously founded and ran the health enterprise SundhedsDoktor A/S. In 2015, he co-founded Liva Healthcare alongside the co-founders of NetDoctor, Rune Bech and Dr Carl Brandt.


Moderators (4)

Sarah Neville

Sarah Neville

Global Pharmaceuticals Editor
Financial Times

Sarah Neville is Global Pharmaceuticals Editor of the Financial Times, a position she has held since 2016. She joined the Financial Times in 2001 and has held a series of senior roles, including Weekend News Editor, Analysis Editor, UK News Editor and Public Policy Editor. She began her career on local and regional newspapers, eventually becoming Political Editor of the Yorkshire Post. In 1995 she was awarded the Laurence Stern Fellowship on the Washington Post. 

Mamta Badkar

Mamta Badkar

fastFT Reporter
Financial Times

Mamta Badkar is a fastFT Reporter for the Financial Times based in New York.  Ms Badkar was previously a senior reporter at Business Insider covering emerging markets, US housing, and wealth management. Prior to that she was a cultural reporter for Verve magazine in India.  

In 2010 Ms Badkar graduated from Columbia University Graduate School of Journalism in New York where she spent a year reporting in the Bronx. While at Columbia, she also spent 10-days reporting from Jordan and Israel as part of her course. She has a Bachelor of Arts in English from St. Xavier's College. She is fluent in Hindi.

Chris Zant

Chris Zant

Principal, Life Sciences
Deloitte Digital

Christopher Zant, Deloitte Digital Leader for Life Sciences, helps life sciences companies transform their commercial businesses through effective and compliant delivery of digital strategy, process, and technology. Mr Zant guides life science companies through complex multi-channel programs with an understanding that the north star of digital is people. He helps his clients bridge the gap between the art and science of their digital strategies with the knowledge that, at its core, digital is about the motivations and behaviors that drive relationships, connections, knowledge, and trust. With 25 years of life sciences consulting experience, Mr Zant understands the business requirements and enablers that help his clients optimize the patient and health care practitioner experience while streamlining operations and improving financial performance. He excels in project management and leading clients through complex technology programs. His client list includes many of the top global life sciences companies in areas such as patient services, multi-channel marketing, call centers, digital production, market access, sales force automation, and outsourcing. He is passionate about empowering patients to manage their journey through digital technology, and sponsors Deloitte’s Patient Connect platform which helps life sciences companies leverage digital capabilities to develop and strengthen bonds with patients, caregivers, and health care practitioners.

Outside Deloitte Mr Zant is a general aviation pilot who donates his time as a pilot and board member for Angel Flight East, a nonprofit dedicated to providing free air transportation for people with medical conditions requiring treatment far from home. He earned his bachelor’s degree in Management Information Systems from New York University.

Peter Micca

Peter Micca

Partner, Life Sciences & Health Care

Pete Micca is a partner with 30 years of experience in the health care and life sciences industry. He has worked across the industry with companies including health plans (commercial, Medicare, Medicaid, and Medicare Advantage operations), life sciences (pharmaceuticals, pharmacy benefit managers, medical devices, distribution, health tech and health services and biotechnology organizations) and health care providers (accountable care organizations and retail health and services.)

Pete is currently the National Audit Industry Leader, Health Plans. He previously served as National Assurance and Enterprise Risk Services Industry Leader, Health Plans, and has significant experience working with audit, advisory, consulting and tax on cross-functional industry solutions, resources and go to market strategies. Pete also leads Deloitte’s national cross-sector go to market strategy around the emergence of Health Tech and Health Services within the industry. 

Pete has served on the board of advisors of St. John’s University College of Business and of the Executive Business Program at Columbia University.


Agenda - 17th Oct

  • 8:00am
    Registration and networking
  • 8:50am
    Chair’s opening remarks

    Sarah Neville, Global Pharmaceuticals Editor, Financial Times

  • 9:00am
    Keynote address: New approaches to relieving pressures in healthcare

    Aneesh Chopra, Former US Chief Technology Officer and President, CareJourney

  • 9:20am
    Health leaders’ panel: Bringing value to healthcare

    Escalating costs and reimbursement demands are exerting ever growing pressure on services.  National health spending is projected to increase by 5.3% in 2018 and reach 20% of GDP by 2026.  Whilst innovation has much to offer in terms of easing the strain, unlocking the value of disruption is beset by challenges, not least those posed by issues of security, engagement and integration. This opening panel will assess best practices and the role of digital technology in achieving value-based care.

    • Understanding technology’s value stream in healthcare. How can disruption help curb spending and deliver more adaptable, patient-driven and efficient healthcare?
    • In what ways can value-based care be incorporated into current business models? How can digital disruption help with reimbursement pathways?
    • Capturing and harnessing the value of data to drive more effective primary care
    • Managing and mitigating risk to ensure that information is not leaked or compromised

    Adam Landman, Vice President and Chief Information Officer, Brigham Health

    Nelia Padilla, Global Lead, Digital Health, IQVIA

    Chet Robson, Medical Director, Clinical Programs and QualityWalgreens 

    Moderator:   Sarah Neville, Global Pharmaceuticals Editor, Financial Times

  • 10:05am
    Regulation in the digital era of health

    Creating a safe and secure healthcare environment.  Panel discussion on the management of regulatory, compliance, privacy and data security risks associated with the use of software, hardware and social media in healthcare

    John Conrad, Principal Regulatory and Operational Risk, Deloitte

    Judy Sewards, Vice President, Digital Innovation, Pfizer

    Mona Siddiqui, Chief Data Officer, Department of Health and Human Services

    Krista Woodley, Senior Director, Quality Healthcare Technology, Johnson & Johnson

    Moderator:   Sarah Neville, Global Pharmaceuticals Editor, Financial Times

  • 10:50am
    Networking break
  • 11:20am
    Investment insights: Riding the wave

    Investment in healthcare technology remains buoyant, 2017 was another record-breaking year for corporate and venture funding.  In the past 12 months there has been a wave of consolidation and collaboration and new entrants and alliances are embracing digital health.  How are investors and big tech viewing the prospects?  How long can the upward trend continue? What is needed to gain investment in an increasingly crowded market?  A panel of finance experts will analyse the options and consider what the future holds for digital health funding.

    Jon Gordon, Director, NewYork-Presbyterian Ventures

    Sue Siegel, Chief Innovation Officer and CEO Business Innovations, GE

    Moderator:  Peter Micca, Partner, Life Science and Health Care, Deloitte

  • 11:55am
    Discussion Panel: Proactive approaches to health

    With more and more people experiencing chronic preventable conditions, transforming medicine from reactive to proactive mode is central to relieving the cost burden on healthcare systems. This discussion will explore what technology can do for prevention and prediction and to bring about the shift to proactive, participative healthcare.

    • Technology as an enabler to healthy lifestyles. How to build momentum in consumer activation and help individuals to take ownership of their health and wellness
    • Mining the value of data to make healthcare more proactive, personalised and precise. How are advances in genomics, AI and machine learning aiding prediction and facilitating the transition?
    • The growing use of predictive algorithms
    • In what ways are employers capitalizing on the revolution in technology, data and analytics to improve employee health and quality of care?

    Keynote:  Ann Mond Johnson, Chief Executive Officer, American Telemedicine Association


    Freddy Abnousi, Head of Healthcare - Research, Facebook

    Jason Gorevic, CEO, Teladoc Health

    Steve Ommen, Associate Dean, Center for Connected Care, Mayo Clinic

    Marcus Osborne, Vice President, Health and Wellness Transformation, Walmart

    Moderator:   Mamta Badkar, fastFT Reporter, Financial Times

  • 12:40pm
    Circular dialogues

    Delegates are joined at their tables by the speakers to discuss the topics from the earlier sessions.  This is an opportunity to engage with fellow participants, join the debate and share ideas and experiences.

  • 1:00pm
  • 2:00pm
    Digital health discussion: The transformation of the pharma-patient relationship

    Long, costly and inefficient R&D processes have much to gain from improved patient engagement and experiences.    The development and adoption of digital technology can change the way pharma is able to interact with patients, incorporate their input and achieve better outcomes and returns on investment.   However navigating the complexities of implementing digital strategies and meeting the evolving needs of individuals is no easy task for a sector that has been traditionally slow to adapt.

    • How is the relationship between pharma and patients changing? What is needed to build trust and engagement?
    • What are the digital game-changers in drug discovery?
    • The use of wearable and mobile applications to enhance patient recruitment, retention and adherence
    • Case studies of incorporating the patient voice and designing patient-friendly clinical trials
    • How is regulation evolving and what barriers does it pose?

    Heather Bell, Senior Vice President, Global Head of Digital and Analytics, Sanofi

    Paul Ivsin, Managing Director, Clinical Trial Strategy and Recruitment, The Patient Experience Project

    Saskia Steinacker, Vice President and Global Lead Digital Transformation, Bayer

    Moderator:  Chris Zant, Principal , Life Sciences, Deloitte Digital

  • 2:40pm
    Special focus: The mental health opportunity

    Ten million adults in the US are living with a serious mental illness and estimates suggest that only half of these people receive treatment. Digital technologies present opportunities to facilitate more flexible access to support, specialist care and therapy and improve patient experience and outcomes. This session will look at how to broaden the frontiers of diagnosis and treatment and disrupt the impact of mental illnesses.

    • How do you introduce digital touchpoints to improve mental health and tailor technologies to suit the individual’s needs?
    • The use of smart phones together with cognitive technology and AI to boost understanding of mental health and benefit patients
    • Exploiting social media platforms to overcome stigma and identify users who could be suffering from mental health problems

    Nancy Lublin, CEO and Founder, Crisis Text Line

    Mimi McFaul, Deputy Director, National Mental Health Innovation Center

    John Torous, Director of the Digital Psychiatry Division, Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School

    Moderator:   Mamta Badkar, fastFT Reporter, Financial Times

  • 3:20pm
    In Conversation with the FT: Closing the health divide – global perspectives

    Steering disruption to make worldwide healthcare more affordable and accessible 

    David Ross, President and CEO, The Task Force for Global Health

    Marcelo de Almeida Fonseca, Director, dr.consulta

    Moderator:   Mamta Badkar, fastFT Reporter, Financial Times

  • 4:00pm
    Technology Spotlight: Value-creating solutions for healthcare

    This final session will give the stage to the innovators and entrepreneurs who are pushing the limits of disease understanding, diagnosis and therapy. Companies will present their solutions and discuss their impact on healthcare costs and outcomes. What real-world evidence do they have and how are they able to demonstrate the value of their disruption?  How can they gain investment and consumer traction, and close the gap between product development and adoption?

    Abdullah Albeyatti, Co-founder and CEO, Medicalchain

    Kristoffer From, CEO, Liva Healthcare

    Moderator:   Sarah Neville, Global Pharmaceuticals Editor, Financial Times

  • 4:40pm
    Closing remarks: Sarah Neville, Global Pharmaceuticals Editor, Financial Times
  • 4:45pm
    Networking Drinks Reception

Photos from the 2017 Summit

See photos from the 2017 summit here

dhusa photo


Why Attend?

  • Assess how patients are continuing to take more control of their own value-based healthcare
  • Take home ideas that will allow your own business to specifically target the latest consumer and patient demands
  • Better identify cyber threats and reduce information security risks
  • Find out how innovators are closing the gap between product development and adoption
  • Hear the latest from pharma and biotech leaders who have strong influence on the digital uptake in medicine

Who Attends?

FT Live has a reputation for delivering very senior board level audiences to attend a wide range of world class thought-leadership events across the globe for nearly 40 years. 

The FT Digital Health Summit USA will be attended by: 

- Pharmaceutical and biotechnology companies 
- Healthcare Providers
- Medical Device manufacturers 
- Health insurers
- Investment banks 
- Hospital Management
- Clinicians 


With the Support Of (1)

About Life Sciences and Health Care at Deloitte*

Deloitte’s life sciences and health care (LSHC) industry group is composed of over 12,000 professionals in over 90 countries. These professionals understand the complexity of today’s life sciences and health care industry challenges, and provide clients with integrated, comprehensive services that meet their respective needs. In today’s environment, LSHC professionals from across the Deloitte network help companies to evolve in a changing marketplace, pursue new and innovative solutions, and sustain long-term profitability.

For more information, visit or email

*Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (DTTL), a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity.

Lead Sponsor (1)

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Associate Sponsors (3)

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 55,000 employees worldwide. Learn more at

Medicalchain is a decentralized platform that enables secure and transparent exchange and usage of health records. Utilising blockchain technology, Medicalchain creates a single true version of an individual’s electronic health records, ensuring the right data is available to the right professional at the right time. Medicalchain is built on the permission based Hyperledger Fabric architecture.  Medicalchain is also a platform for other digital health application developers; users will be able to access these applications and services, which are powered by their health data and secured by smart contracts. Medicalchain is developing a global telemedicine application, which will enable users to consult a real doctor remotely for a small fee payable directly to the doctor. The telemedicine application will be first piloted in a small group of NHS and Private GP practices in London, UK

Teladoc Health, Inc. (NYSE:TDOC) is the world’s largest and most trusted provider of virtual healthcare delivery services. The company is transforming access to care with a virtual healthcare delivery platform that delivers better outcomes, convenience and value. Built on a foundation of quality that includes a global network of 50,000 medical experts across 450 subspecialties, Teladoc Health is making a better healthcare experience possible with access to high quality care that spans the spectrum from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. Through unmatched scale, Teladoc Health serves more than 40M members across 100 countries. By marrying the latest in data and analytics with its award-winning user experience and highly flexible technology platform, Teladoc Health has delivered millions of medical visits to patients around the globe.

Supporting Partners (3)

The Digital Therapeutics Alliance is a global non-profit trade association with the mission of broadening the understanding, adoption, and integration of clinically-validated digital therapeutics into healthcare through education, advocacy, and research. Digital therapeutics deliver medical interventions via clinically-validated technologies to prevent, manage, and treat medical conditions and may be used independently or in conjunction with therapeutic pathways to optimize patient care and health outcomes

FT Health
The essential briefing for decision makers in health

FT Health is a weekly guide to the news and analysis that matters for decision makers in government, healthcare, research, industry and policy-making around the world. Leading specialists curate the best articles from the FT and across the web and make the links between the big issues. FT Health signposts important coverage on topics including infectious and non-communicable disease, public health, healthcare policy and practice, public health, research, development, drugs, vaccines and diagnostics. Straight to your inbox every Friday.

StartUp Health is on a 25-year mission to collaborate with entrepreneurs to improve the health and wellbeing of everyone in the world. StartUp Health believes that something magical happens when you bring together coachable entrepreneurs from around the world who have the mindset to achieve health moonshots. Since 2011, StartUp Health has been investing in a global army of entrepreneurs -- called Health Transformers® -- to achieve Health Moonshots: Access to Care, Cost to Zero, Cure Disease, End to Cancer, Women’s Health, Children’s Health, Nutrition & Fitness, Brain Health, Mental Health & Happiness, Longevity, and End Addiction.

Backed by Advocate Aurora Health, Chiesi Group, Steve Case, Mark Cuban, Esther Dyson, Brad Feld, GuideWell, Jason Finger, Jerry Levin, Kaiser Permanente Ventures, Masimo, Novartis, Otsuka, and Ping An Group, StartUp Health has the world’s largest digital health portfolio with more than 250 companies spanning six continents and 21 countries. Learn more at


10 on the Park
60 Columbus Circle
10th Floor
New York 10019

United States of America

Tel: +1 212-484-6600


Nearby Accommodations

We have put together a unique Hotel Map that shows hotel deals close to the event venue. To view, click here.


Contact Us

Meredith Vachon
Media Partner & Press Inquiries
Financial Times
Ailsa Matkevich
Speaking Opportunities
Financial Times
Joe Hames
Sponsorship Opportunities
Financial Times